-
- 抗原 See all CERK 抗体
- CERK (Ceramide Kinase (CERK))
-
抗原表位
- AA 487-516, C-Term
-
适用
- 人, 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This CERK antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 纯化方法
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- 免疫原
- This CERK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 487-516 amino acids from the C-terminal region of human CERK.
- 克隆位点
- RB5271
- 亚型
- Ig Fraction
- Top Product
- Discover our top product CERK Primary Antibody
-
-
- 应用备注
- WB: 1:1000. WB: 1:1000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
- 有效期
- 6 months
-
-
ATRA inhibits ceramide kinase transcription in a human neuroblastoma cell line, SH-SY5Y cells: the role of COUP-TFI." in: Journal of neurochemistry, Vol. 112, Issue 2, pp. 511-20, (2010) (PubMed).
: "Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 29, Issue 8, pp. 1213-9, (2009) (PubMed).
: "Ceramide kinase promotes Ca2+ signaling near IgG-opsonized targets and enhances phagolysosomal fusion in COS-1 cells." in: Journal of lipid research, Vol. 49, Issue 3, pp. 531-42, (2008) (PubMed).
: "
-
ATRA inhibits ceramide kinase transcription in a human neuroblastoma cell line, SH-SY5Y cells: the role of COUP-TFI." in: Journal of neurochemistry, Vol. 112, Issue 2, pp. 511-20, (2010) (PubMed).
-
- 抗原
- CERK (Ceramide Kinase (CERK))
- 别名
- CERK (CERK 产品)
- 别名
- AI848610 antibody, D330016D08Rik antibody, mKIAA1646 antibody, LK4 antibody, dA59H18.2 antibody, dA59H18.3 antibody, hCERK antibody, CERK antibody, si:ch211-162i19.1 antibody, MGC81777 antibody, CG16708 antibody, DCERK antibody, Dcerk antibody, Dmel\\CG16708 antibody, dcerk antibody, ceramide kinase antibody, ceramide kinase S homeolog antibody, Ceramide kinase antibody, Cerk antibody, CERK antibody, cerk antibody, cerk.S antibody, CpipJ_CPIJ003342 antibody, LOAG_11245 antibody, LOC5579301 antibody, Bm1_50005 antibody
- 背景
- Ceramide kinases convert the sphingolipid metabolite ceramide into ceramide-1-phosphate, both key mediators of cellular apoptosis and survival. Ceramide metabolism plays an essential role in the viability of neuronal cells, the membranes of which are particularly rich in sphingolipids. CERK catalyzes specifically the phosphorylation of ceramide to form ceramide 1-phosphate. This enzyme acts efficiently on natural and analog ceramides (C6, C8, C16 ceramides, and C8 dihydroceramide), and to a lesser extent on C2-ceramide and C6-dihydroceramide, but not on other lipids, such as various sphingosines. High level expression is noted in heart, brain, skeletal muscle, kidney and liver, moderate expression in peripheral blood leukocytes and thymus, and low expression in spleen, small intestine, placenta and lung.
- 基因ID
- 64781
- NCBI登录号
- NP_073603
- UniProt
- Q8TCT0
-